A Claudin-Based Molecular Signature Identifies High-Risk, Chemoresistant Colorectal Cancer Patients

Identifying molecular characteristics that are associated with aggressive cancer phenotypes through gene expression profiling can help predict treatment responses and clinical outcomes. Claudins are deregulated in colorectal cancer (CRC). In CRC, increased claudin-1 expression results in epithelial-...

Descripción completa

Detalles Bibliográficos
Autores principales: Gowrikumar, Saiprasad, Primeaux, Mark, Pravoverov, Kristina, Wu, Chao, Szeglin, Bryan C., Sauvé, Charles-Etienne Gabriel, Thapa, Ishwor, Bastola, Dhundy, Chen, Xi Steven, Smith, J. Joshua, Singh, Amar B., Dhawan, Punita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466455/
https://www.ncbi.nlm.nih.gov/pubmed/34571860
http://dx.doi.org/10.3390/cells10092211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466455/
https://www.ncbi.nlm.nih.gov/pubmed/34571860
http://dx.doi.org/10.3390/cells10092211

Ejemplares similares